BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 19129533)

  • 21. Family increases: UPLIFT first maintenance subgroup analysis.
    Puente-Maestú L; De Miguel J
    Eur Respir J; 2010 Jul; 36(1):10-1. PubMed ID: 20595162
    [No Abstract]   [Full Text] [Related]  

  • 22. [Combination of inhaled salmeterol/fluticasone and tiotropium in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial].
    Fang LZ; Liang X; Zhang JQ; Liu L; Fu WP; Zhao ZH; Dai LM
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Nov; 31(11):811-4. PubMed ID: 19080533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiotropium versus salmeterol in COPD.
    Schembri S
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714655
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimizing maintenance therapy for chronic obstructive pulmonary disease: strategies for improving patient-centered outcomes.
    Hanania NA
    Clin Ther; 2007 Oct; 29(10):2121-33. PubMed ID: 18042470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does tiotropium reduce hospitalizations in chronic obstructive pulmonary disease?
    Oba Y
    Ann Intern Med; 2008 Apr; 148(8):626; author reply 626-7. PubMed ID: 18413628
    [No Abstract]   [Full Text] [Related]  

  • 26. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
    Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
    N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of tiotropium in the hospital management of exacerbation of chronic obstructive pulmonary disease.
    Tashkin DP
    Respir Care; 2008 Dec; 53(12):1657-9. PubMed ID: 19025697
    [No Abstract]   [Full Text] [Related]  

  • 28. Chronic obstructive pulmonary disease.
    Kerstjens H; Postma D; ten Hacken N
    Clin Evid; 2005 Jun; (13):1923-47. PubMed ID: 16135316
    [No Abstract]   [Full Text] [Related]  

  • 29. Choice of medications when treating stable COPD.
    Vestbo J
    Clin Respir J; 2010 Oct; 4(4):195-6. PubMed ID: 20887340
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic obstructive pulmonary disease: the evidence for use of tiotropium.
    Burns G; Bianchi S
    Br J Hosp Med (Lond); 2006 Feb; 67(2):85-91. PubMed ID: 16498916
    [No Abstract]   [Full Text] [Related]  

  • 32. Incorporating tiotropium into a respiratory therapist-directed bronchodilator protocol for managing in-patients with COPD exacerbations decreases bronchodilator costs.
    Drescher GS; Carnathan BJ; Imus S; Colice GL
    Respir Care; 2008 Dec; 53(12):1678-84. PubMed ID: 19025702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticholinergic agents in asthma and COPD.
    Gross NJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):36-9. PubMed ID: 16488410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiotropium versus salmeterol in COPD.
    Oba Y
    N Engl J Med; 2011 Jun; 364(26):2553; author reply 2553-4. PubMed ID: 21714654
    [No Abstract]   [Full Text] [Related]  

  • 35. [Debates surrounding COPD].
    Tillie-Leblond I; Housset B
    Rev Mal Respir; 2010 Feb; 27(2):106-7. PubMed ID: 20206057
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-acting bronchodilator agents are the choice in COPD. Keeping the airways open continuously].
    MMW Fortschr Med; 2007 Nov; 149(47):54. PubMed ID: 18064817
    [No Abstract]   [Full Text] [Related]  

  • 37. Tiotropium in the management of chronic obstructive pulmonary disease.
    Rees PJ
    Eur Respir J; 2002 Feb; 19(2):205-6. PubMed ID: 11865999
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of chronic obstructive pulmonary disease.
    Barr RG
    JAMA; 2004 Mar; 291(9):1066-7; author reply 1067. PubMed ID: 14996770
    [No Abstract]   [Full Text] [Related]  

  • 39. Triple therapy trials in COPD: a precision medicine opportunity.
    Suissa S; Ariel A
    Eur Respir J; 2018 Dec; 52(6):. PubMed ID: 30545959
    [No Abstract]   [Full Text] [Related]  

  • 40. [New cholinergic drugs in asthma and COPD].
    Kuś J
    Pneumonol Alergol Pol; 2002; 70 Suppl 1():61-3. PubMed ID: 12518641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.